Souheil El-Chemaly1, Daniela Malide2, Jianhua Yao3, Steven D Nathan4, Ivan O Rosas5, William A Gahl6, Joel Moss7, Bernadette R Gochuico6. 1. Cardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA. Electronic address: sel-chemaly@partners.org. 2. Light Microscopy Core Facility, National Institutes of Health, Bethesda, MD. 3. National Heart, Lung, and Blood Institute, the Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD. 4. Inova Fairfax Hospital, Falls Church, VA. 5. Cardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA. 6. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD. 7. Cardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD.
Abstract
BACKGROUND: [¹⁸F]-2-fluoro-2-deoxyglucose (FDG)-PET scan uptake is increased in areas of fibrosis and honeycombing in patients with idiopathic pulmonary fibrosis (IPF). Glucose transporter-1 (Glut-1) is known to be the main transporter for FDG. There is a paucity of data regarding the distribution of Glut-1 and the cells responsible for FDG binding in fibrotic lung diseases. METHODS: We applied immunofluorescence to localize Glut-1 in normal, IPF, and Hermansky-Pudlak syndrome (HPS) pulmonary fibrosis lung tissue specimens as well as an array of 19 different lung neoplasms. In addition, we investigated Glut-1 expression in inflammatory cells from BAL fluid (BALF) from healthy volunteers, subjects with IPF, and subjects with HPS pulmonary fibrosis. RESULTS: In normal lung tissue, Glut-1 immunoreactivity was seen on the surface of erythrocytes. In tissue sections from fibrotic lung diseases (IPF and HPS pulmonary fibrosis), Glut-1 immunoreactivity was present on the surface of erythrocytes and inflammatory cells. BALF inflammatory cells from healthy control subjects showed no immunoreactivity; BALF cells from subjects with IPF and HPS pulmonary fibrosis showed Glut-1 immunoreactivity associated with neutrophils and alveolar macrophages. CONCLUSIONS: Glut-1 transporter expression in normal lung is limited to erythrocytes. In fibrotic lung, erythrocytes and inflammatory cells express Glut-1. Together, these data suggest that FDG-PET scan uptake in IPF could be explained by enhanced inflammatory and erythrocytes uptake due to neovascularization seen in IPF and not an upregulation of metabolic rate in pneumocytes. Thus, FDG-PET scan may detect inflammation and neovascularization in lung fibrosis.
BACKGROUND: [¹⁸F]-2-fluoro-2-deoxyglucose (FDG)-PET scan uptake is increased in areas of fibrosis and honeycombing in patients with idiopathic pulmonary fibrosis (IPF). Glucose transporter-1 (Glut-1) is known to be the main transporter for FDG. There is a paucity of data regarding the distribution of Glut-1 and the cells responsible for FDG binding in fibrotic lung diseases. METHODS: We applied immunofluorescence to localize Glut-1 in normal, IPF, and Hermansky-Pudlak syndrome (HPS) pulmonary fibrosis lung tissue specimens as well as an array of 19 different lung neoplasms. In addition, we investigated Glut-1 expression in inflammatory cells from BAL fluid (BALF) from healthy volunteers, subjects with IPF, and subjects with HPS pulmonary fibrosis. RESULTS: In normal lung tissue, Glut-1 immunoreactivity was seen on the surface of erythrocytes. In tissue sections from fibrotic lung diseases (IPF and HPS pulmonary fibrosis), Glut-1 immunoreactivity was present on the surface of erythrocytes and inflammatory cells. BALF inflammatory cells from healthy control subjects showed no immunoreactivity; BALF cells from subjects with IPF and HPS pulmonary fibrosis showed Glut-1 immunoreactivity associated with neutrophils and alveolar macrophages. CONCLUSIONS:Glut-1 transporter expression in normal lung is limited to erythrocytes. In fibrotic lung, erythrocytes and inflammatory cells express Glut-1. Together, these data suggest that FDG-PET scan uptake in IPF could be explained by enhanced inflammatory and erythrocytes uptake due to neovascularization seen in IPF and not an upregulation of metabolic rate in pneumocytes. Thus, FDG-PET scan may detect inflammation and neovascularization in lung fibrosis.
Authors: K Higashi; Y Ueda; H Seki; K Yuasa; M Oguchi; T Noguchi; M Taniguchi; H Tonami; T Okimura; I Yamamoto Journal: J Nucl Med Date: 1998-06 Impact factor: 10.057
Authors: Gregory P Cosgrove; Kevin K Brown; William P Schiemann; Amanda E Serls; Jane E Parr; Mark W Geraci; Marvin I Schwarz; Carlyne D Cool; G Scott Worthen Journal: Am J Respir Crit Care Med Date: 2004-04-29 Impact factor: 21.405
Authors: Dong Wang; Juan M Pascual; Hong Yang; Kristin Engelstad; Xia Mao; Jianfeng Cheng; Jong Yoo; Jeffrey L Noebels; Darryl C De Vivo Journal: Hum Mol Genet Date: 2006-02-23 Impact factor: 6.150
Authors: Cecelia S Yap; Christiaan Schiepers; Michael C Fishbein; Michael E Phelps; Johannes Czernin Journal: Eur J Nucl Med Mol Imaging Date: 2002-06-04 Impact factor: 9.236
Authors: Mahefatiana Andrianifahanana; Danielle M Hernandez; Xueqian Yin; Jeong-Han Kang; Mi-Yeon Jung; Youli Wang; Eunhee S Yi; Anja C Roden; Andrew H Limper; Edward B Leof Journal: FASEB J Date: 2016-08-01 Impact factor: 5.191
Authors: Delphine L Chen; Joseph Cheriyan; Edwin R Chilvers; Gourab Choudhury; Christopher Coello; Martin Connell; Marie Fisk; Ashley M Groves; Roger N Gunn; Beverley F Holman; Brian F Hutton; Sarah Lee; William MacNee; Divya Mohan; David Parr; Deepak Subramanian; Ruth Tal-Singer; Kris Thielemans; Edwin J R van Beek; Laurence Vass; Jeremy W Wellen; Ian Wilkinson; Frederick J Wilson Journal: J Nucl Med Date: 2017-01-12 Impact factor: 10.057
Authors: Peter McErlean; Christopher G Bell; Richard J Hewitt; Zabreen Busharat; Patricia P Ogger; Poonam Ghai; Gesa J Albers; Emily Calamita; Shaun Kingston; Philip L Molyneaux; Stephan Beck; Clare M Lloyd; Toby M Maher; Adam J Byrne Journal: Am J Respir Crit Care Med Date: 2021-10-15 Impact factor: 21.405
Authors: Thomas Bertero; Katherine A Cottrill; Sofia Annis; Balkrishen Bhat; Bernadette R Gochuico; Juan C Osorio; Ivan Rosas; Kathleen J Haley; Kathleen E Corey; Raymond T Chung; B Nelson Chau; Stephen Y Chan Journal: Sci Rep Date: 2015-12-15 Impact factor: 4.379